Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,055,225,633
+$2,169,393,573 QoQ
Shares Held
24,771,828
+31.9% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 73.65914215131802.ToString("F0")%
Shared 0.ToString("F0")%
None 26.34085784868198.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FMR LLC holds $65,159,031,340 across 17 Drug Manufacturers - General names. JNJ ranks #3 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,341,031 | $24,227,690,080 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
71,906,290 | $10,021,579,632 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
24,771,828 | $6,055,225,633 | |
| 4 | AZN |
Astrazeneca PLC
|
29,601,724 | $5,838,052,004 | |
| 5 | MRK |
Merck & Co., Inc.
|
44,516,010 | $5,354,830,840 | |
| 6 | ABBV |
AbbVie Inc.
|
21,762,703 | $4,733,170,273 | |
| 7 | GSK |
GSK plc
|
67,661,646 | $3,734,246,242 | |
| 8 | BIIB |
Biogen Inc.
|
12,807,541 | $2,348,006,489 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,055,225,633 | 24,771,828 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,885,832,060 | 18,776,671 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,492,680,231 | 13,443,427 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,050,130,303 | 13,421,475 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,286,692,633 | 13,788,547 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,325,479,328 | 16,079,929 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,968,440,051 | 18,316,920 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,492,199,296 | 17,051,172 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,669,860,422 | 16,877,555 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,610,447,644 | 16,654,636 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,782,208,195 | 17,863,295 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,459,419,143 | 20,900,309 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,750,894,430 | 17,747,706 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $3,372,630,062 | 19,092,160 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,097,027,068 | 18,958,295 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,323,883,446 | 18,725,049 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,746,359,090 | 15,496,017 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,122,660,507 | 12,408,140 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,082,195,597 | 12,892,852 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $2,193,492,505 | 13,314,875 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,143,868,831 | 13,044,532 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,177,891,009 | 13,838,423 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,265,381,602 | 15,216,158 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,255,390,187 | 16,037,760 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $2,247,989,911 | 17,143,216 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||